AU697656B2 - Bicyclolactam compounds, use thereof and intermediates for preparing thereof - Google Patents

Bicyclolactam compounds, use thereof and intermediates for preparing thereof

Info

Publication number
AU697656B2
AU697656B2 AU59118/96A AU5911896A AU697656B2 AU 697656 B2 AU697656 B2 AU 697656B2 AU 59118/96 A AU59118/96 A AU 59118/96A AU 5911896 A AU5911896 A AU 5911896A AU 697656 B2 AU697656 B2 AU 697656B2
Authority
AU
Australia
Prior art keywords
effect
intermediates
preparing
bicyclolactam
represents hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU59118/96A
Other versions
AU5911896A (en
Inventor
Takashi Arima
Manabu Kaneda
Kazuo Ogawa
Junji Yamamoto
Ichiro Yamawaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of AU5911896A publication Critical patent/AU5911896A/en
Application granted granted Critical
Publication of AU697656B2 publication Critical patent/AU697656B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bicyclolactam compounds represented by general formula (1) are useful as the active ingredient of medicines having an excellent anxiolytic effect and a high safety with little side effects such as a hypnotic effect, a muscle relaxing effect, a sedative effect, etc. In said formula, R represents oxo or -OR<1> (wherein R<1> represents hydrogen or acyl); A represents one of the following groups (2) and (3); Q represents hydrogen or lower alkyl; l is 1 or 2, m is 0 or 1; and n is 0, 1 or 2, provided that m and n are not 0 at the same time; R<2> represents optionally substituted benzoyl.
AU59118/96A 1995-06-12 1996-06-07 Bicyclolactam compounds, use thereof and intermediates for preparing thereof Ceased AU697656B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP7-170329 1995-06-12
JP17032995 1995-06-12
JP7-274654 1995-09-27
JP27465495A JP3161948B2 (en) 1995-06-12 1995-09-27 Bicyclolactam compound
PCT/JP1996/001565 WO1996041796A1 (en) 1995-06-12 1996-06-07 Bicyclolactam compounds, use of the same and intermediate in the production of the same

Publications (2)

Publication Number Publication Date
AU5911896A AU5911896A (en) 1997-01-09
AU697656B2 true AU697656B2 (en) 1998-10-15

Family

ID=26493354

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59118/96A Ceased AU697656B2 (en) 1995-06-12 1996-06-07 Bicyclolactam compounds, use thereof and intermediates for preparing thereof

Country Status (10)

Country Link
JP (1) JP3161948B2 (en)
KR (1) KR100220172B1 (en)
AT (1) ATE224369T1 (en)
AU (1) AU697656B2 (en)
CA (1) CA2197178C (en)
DE (1) DE69623747T2 (en)
DK (1) DK0790237T3 (en)
ES (1) ES2183956T3 (en)
PT (1) PT790237E (en)
WO (1) WO1996041796A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995026187A1 (en) * 1994-03-28 1995-10-05 Taiho Pharmaceutical Company, Ltd. Anxiolytic agent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0466933B1 (en) * 1990-02-02 1995-11-22 Taiho Pharmaceutical Company Limited Bicyclolactam derivative

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995026187A1 (en) * 1994-03-28 1995-10-05 Taiho Pharmaceutical Company, Ltd. Anxiolytic agent

Also Published As

Publication number Publication date
ES2183956T3 (en) 2003-04-01
KR100220172B1 (en) 1999-09-01
AU5911896A (en) 1997-01-09
JP3161948B2 (en) 2001-04-25
WO1996041796A1 (en) 1996-12-27
CA2197178C (en) 2001-05-01
KR970704686A (en) 1997-09-06
ATE224369T1 (en) 2002-10-15
CA2197178A1 (en) 1996-12-27
DE69623747D1 (en) 2002-10-24
PT790237E (en) 2003-02-28
JPH0959251A (en) 1997-03-04
DE69623747T2 (en) 2003-05-22
DK0790237T3 (en) 2002-10-14

Similar Documents

Publication Publication Date Title
CA2146852A1 (en) New substituted pyrazole derivatives, processes for their preparation and their use as herbicides
AU2514792A (en) 1-substituted 1h-imidazo(4,5-c)quinolin-4-amines; intermediate and pharmaceutical compositions
WO1993014070A3 (en) Novel imidazole derivatives, their preparation and therapeutic applications
CA2174494A1 (en) Benzofurans
ES470155A1 (en) Spiro-4&#39;-piperidine compounds and their pharmaceutical compositions
WO2002000638A3 (en) Substituted phthalides as anti-convulsive drugs
IL111966A0 (en) 4-Benzoylisoxazole derivatives, their preparation and herbicidal compositions containing them
CA2137961A1 (en) Cyclic depsipeptides having 18 ring atoms, and their use for combating endoparasites
AU697656B2 (en) Bicyclolactam compounds, use thereof and intermediates for preparing thereof
AU3443593A (en) 4-oxo- and 4H-imidazo(5,1-C)(1,4)benzoxazines useful as benzodiazepine receptor-binding agents
HUT74710A (en) Herbicidal pyrrolopyridine compounds, compositions containing them and use thereof
EP0790237A4 (en) Bicyclolactam compounds, use of the same and intermediate in the production of the same
IL104478A (en) N-5-protected 2,5-diamino-4, 6-dichloropyrimidines and processes for their preparation
NZ229300A (en) Substituted-2-ethenyl-3,4,5,6-tetrahydrothieno (4,3,2-cf)(3)benzazepine derivatives and pharmaceutical compositions
HU9904686D0 (en) New hydroxy-bicyclolactam derivatives, their use and medicaments containing them
MX9801201A (en) Fungicidal mixtures of an oximether carboxylic acid amide with anilinopyrimidines.
CA2027542A1 (en) Uv-absorbing cyclic enaminoketones
TW197946B (en)
ES8703847A1 (en) Sulfonyl-guanidinopyrimidine derivatives.
ES8703855A1 (en) Sulfonyl-guanidinotriazine derivatives.
ZW6889A1 (en) &amp;-adrenergic receptor antagonists
PL312966A1 (en) Derivatives of thiocarbamoil
EP0344981A3 (en) Alpha-adrenergic receptor antagonists
MY115291A (en) New substituted pyrazole derivatives, processes for their preparation nad their use as herbicides
IE45779L (en) Novel anhydro-sugars and a process for their preparation